Baxter International Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Baxter International Inc. on May 5, 2016, reporting an event that occurred on May 3, 2016. The filing addresses a specific executive leadership change within the company's Renal division.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to Item 8.01 (Other Events) and contains no financial data.
Material Changes
The material change reported is a personnel transition in the Renal division:
- Giuseppe Accogli has assumed the role of Interim President, Renal, effective May 3, 2016.
- This appointment follows the departure of Jill Schaaf, who served as President, Renal from May 2014 to May 2016.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items beyond the executive transition.
Key Facts for Investor Verification
- Confirm the effective date of Giuseppe Accogli's interim appointment (May 3, 2016).
- Verify the tenure of the departing executive, Jill Schaaf (May 2014 to May 2016).
- Monitor subsequent filings for the appointment of a permanent President, Renal.